ArticleTargeted oncology2023

Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies.

Sanjay Popat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.